Literature DB >> 15825246

Screening for sexually transmitted diseases and hepatitis in 18-29-year-old men recently released from prison: feasibility and acceptability.

J M Sosman1, R J MacGowan, A D Margolis, E Eldridge, T Flanigan, J Vardaman, C Fitzgerald, D Kacanek, D Binson, D W Seal, C A Gaydos.   

Abstract

Men entering prisons have high rates of sexually transmitted disease (STD), hepatitis, and HIV. This study sought to determine the acceptability and feasibility of screening for STD and hepatitis in young men released from prison. Participants were interviewed six months after release and offered free screening. Of 42 (56%) eligible men who participated in the qualitative interview, 33 (79%) provided at least a blood or urine specimen. Eight of 33 (24%) men tested had chlamydia, trichomoniasis, hepatitis B or C virus (HBV or HCV). Three of 32 (9%) had chlamydia, three of 32 (9%) had trichomoniasis, two of 28 (7%) had prior syphilis, and two of 28 (7%) had HCV. Of 28 tested for HBV, six (21%) were immune, two (7%) had chronic infection, and 20 (71%) were susceptible. Barriers to screening included lack of forewarning, inconvenience, and insufficient incentive. In conclusion, screening for STD and hepatitis among former inmates can be acceptable and feasible. Forewarning, reducing the time burden, and providing monetary incentives may increase screening rates.

Entities:  

Mesh:

Year:  2005        PMID: 15825246     DOI: 10.1258/0956462053057594

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  10 in total

1.  Relative efficacy of a multisession sexual risk-reduction intervention for young men released from prisons in 4 states.

Authors:  Richard J Wolitski
Journal:  Am J Public Health       Date:  2006-10       Impact factor: 9.308

2.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

3.  Substance use and sexual behavior among men prior to parole revocation: prevalence and correlates.

Authors:  David Wyatt Seal; Michelle Parisot; Wayne DiFranceisco
Journal:  J Correct Health Care       Date:  2012-03-14

4.  The status of national HIV case surveillance, United States 2006.

Authors:  M Kathleen Glynn; Lisa M Lee; Matthew T McKenna
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

5.  HIV testing and treatment with correctional populations: people, not prisoners.

Authors:  David Wyatt Seal; Gloria D Eldridge; Barry Zack; James Sosman
Journal:  J Health Care Poor Underserved       Date:  2010-08

6.  Variations in the effect of incarceration on community gonorrhoea rates, Guilford County, North Carolina, 2005-2006.

Authors:  K A Porter; J C Thomas; M E Emch
Journal:  Int J STD AIDS       Date:  2009-11-02       Impact factor: 1.359

7.  Prevalence of HIV, HepBsAg and Hep C antibodies among inmates in Chichiri prison, Blantyre, Malawi.

Authors:  C Chimphambano; Ioo Komolafe; As Muula
Journal:  Malawi Med J       Date:  2007-09       Impact factor: 0.875

Review 8.  A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Authors:  Elissa Meites; Charlotte A Gaydos; Marcia M Hobbs; Patricia Kissinger; Paul Nyirjesy; Jane R Schwebke; W Evan Secor; Jack D Sobel; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

Review 9.  Hepatitis C in European prisons: a call for an evidence-informed response.

Authors:  Amber Arain; Geert Robaeys; Heino Stöver
Journal:  BMC Infect Dis       Date:  2014-09-19       Impact factor: 3.090

10.  Very low sensitivity of wet mount microscopy compared to PCR against culture in the diagnosis of vaginal trichomoniasis in Uganda: a cross sectional study.

Authors:  Sheila Nabweyambo; Othman Kakaire; Stefanie Sowinski; Alfred Okeng; Henry Ojiambo; Joshua Kimeze; Irene Najjingo; Freddie Bwanga
Journal:  BMC Res Notes       Date:  2017-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.